Cardiovascular and Metabolic Risk
Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial
- Cristina Razquin1,2,3,
- Estefanía Toledo1,2,3,
- Clary B. Clish4,
- Miguel Ruiz-Canela1,2,3,
- Courtney Dennis4,
- Dolores Corella3,5,
- Christopher Papandreou3,6,
- Emilio Ros3,7,
- Ramon Estruch3,8,
- Marta Guasch-Ferré3,6,9,
- Enrique Gómez-Gracia3,10,
- Montserrat Fitó3,11,
- Edward Yu9,
- José Lapetra3,12,
- Dong Wang9,
- Dora Romaguera3,13,
- Liming Liang14,15,
- Angel Alonso-Gómez3,16,
- Amy Deik4,
- Mónica Bullo3,6,
- Lluis Serra-Majem3,17,
- Jordi Salas-Salvadó3,6,
- Frank B. Hu9,18 and
- Miguel A. Martínez-González1,2,3,9⇑
- 1Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain
- 2IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
- 3CIBER Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain
- 4Broad Institute of MIT and Harvard University, Cambridge, MA
- 5Department of Preventive Medicine, University of Valencia, Valencia, Spain
- 6Human Nutrition Unit, Faculty of Medicine and Health Sciences, Institut d’Investigació Sanitària Pere Virgili, Rovira i Virgili University, Reus, Spain
- 7Lipid Clinic, Department of Endocrinology and Nutrition, Institut d’Investigacions Biomediques August Pi Sunyer (IDI-BAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain
- 8Department of Internal Medicine, Institut d’Investigacions Biomediques August Pi Sunyer (IDI-BAPS), Barcelona, Spain
- 9Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA
- 10Department of Preventive Medicine, University of Malaga, Malaga, Spain
- 11Cardiovascular and Nutrition Research Group, Institut de Recerca Hospital del Mar, Barcelona, Spain
- 12Research Unit, Department of Family Medicine, Distrito Sanitario Atención Primaria Sevilla, Seville, Spain
- 13Instituto de Investigación Sanitaria Illes Balears (IdISBa), University Hospital of Son Espases, Palma de Mallorca, Spain
- 14Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
- 15Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA
- 16Department of Cardiology, University Hospital of Alava, Vitoria, Spain
- 17Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria, and Service of Preventive Medicine, Complejo Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canary Health Service, Las Palmas de Gran Canaria, Spain
- 18Channing Division for Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
- Corresponding author: Miguel A. Martínez-González, mamartinez{at}unav.es.

Data supplements
Supplementary Data
In this Issue
December 2018, 41(12)
Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial
Cristina Razquin, Estefanía Toledo, Clary B. Clish, Miguel Ruiz-Canela, Courtney Dennis, Dolores Corella, Christopher Papandreou, Emilio Ros, Ramon Estruch, Marta Guasch-Ferré, Enrique Gómez-Gracia, Montserrat Fitó, Edward Yu, José Lapetra, Dong Wang, Dora Romaguera, Liming Liang, Angel Alonso-Gómez, Amy Deik, Mónica Bullo, Lluis Serra-Majem, Jordi Salas-Salvadó, Frank B. Hu, Miguel A. Martínez-González
Diabetes Care Dec 2018, 41 (12) 2617-2624; DOI: 10.2337/dc18-0840
Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial
Cristina Razquin, Estefanía Toledo, Clary B. Clish, Miguel Ruiz-Canela, Courtney Dennis, Dolores Corella, Christopher Papandreou, Emilio Ros, Ramon Estruch, Marta Guasch-Ferré, Enrique Gómez-Gracia, Montserrat Fitó, Edward Yu, José Lapetra, Dong Wang, Dora Romaguera, Liming Liang, Angel Alonso-Gómez, Amy Deik, Mónica Bullo, Lluis Serra-Majem, Jordi Salas-Salvadó, Frank B. Hu, Miguel A. Martínez-González
Diabetes Care Dec 2018, 41 (12) 2617-2624; DOI: 10.2337/dc18-0840